Volume 115, Nº 2, August 2020
DOI: https://doi.org/10.36660/abc.20200424
STATEMENT
Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) – 2020
Alexandre de Matos Soeiro
Tatiana de Carvalho Andreucci Torres Leal
Marcel de Paula Pereira
Eduardo Gomes Lima
Ana Cristina Baptista da Silva Figueiredo
João Luiz Fernandes Petriz
Dalton Betolim Precoma
Carlos Vicente Serrano Jr.
Figure 1 – Management suggestion and flowchart for assessing anticoagulant therapy in critically ill patients with COVID-19. RR: respiratory rate; SIC: sepsis-induced coagulopathy; INR: international normalized ratio; SOFA: sequential organ failure assessment; DIC: disseminated intravascular coagulation; ULN: upper limit of normal.